Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1449187720
总结
CYP2C19 *2 is not associated with increased risk of major adverse cardiac events (mace) when treated with clopidogrel in people with Coronary Artery Disease as compared to CYP2C19 *1/*1.